Fernandez M - Search Results

1

Development of 99mTc(CO)₃-dendrimer-FITC for cancer imaging.

Tassano MR, Audicio PF, Gambini JP, Fernandez M, Damian JP, Moreno M, Chabalgoity JA, Alonso O, Benech JC, Cabral P. Tassano MR, et al. Among authors: fernandez m. Bioorg Med Chem Lett. 2011 Sep 15;21(18):5598-601. doi: 10.1016/j.bmcl.2011.06.079. Epub 2011 Jun 30. Bioorg Med Chem Lett. 2011. PMID: 21778055

2

Live attenuated Salmonella as a vector for oral cytokine gene therapy in melanoma.

Agorio C, Schreiber F, Sheppard M, Mastroeni P, Fernandez M, Martinez MA, Chabalgoity JA. Agorio C, et al. Among authors: fernandez m. J Gene Med. 2007 May;9(5):416-23. doi: 10.1002/jgm.1023. J Gene Med. 2007. PMID: 17410612

3

Identification of chalcones as in vivo liver monofunctional phase II enzymes inducers.

Cabrera M, Lavaggi ML, Croce F, Celano L, Thomson L, Fernández M, Pintos C, Raymondo S, Bollati M, Monge A, López de Ceráin A, Piro OE, Cerecetto H, González M. Cabrera M, et al. Among authors: fernandez m. Bioorg Med Chem. 2010 Jul 15;18(14):5391-9. doi: 10.1016/j.bmc.2010.05.033. Epub 2010 May 20. Bioorg Med Chem. 2010. PMID: 20639112

4

[177Lu]DOTA-anti-CD20: labeling and pre-clinical studies.

Audicio PF, Castellano G, Tassano MR, Rezzano ME, Fernandez M, Riva E, Robles A, Cabral P, Balter H, Oliver P. Audicio PF, et al. Among authors: fernandez m. Appl Radiat Isot. 2011 Jul;69(7):924-8. doi: 10.1016/j.apradiso.2011.01.026. Epub 2011 Jan 26. Appl Radiat Isot. 2011. PMID: 21474325

5

Biological evaluation of glucose and deoxyglucose derivatives radiolabeled with [99mTc(CO)3(H2O)3]+ core as potential melanoma imaging agents.

Dapueto R, Castelli R, Fernández M, Chabalgoity JA, Moreno M, Gambini JP, Cabral P, Porcal W. Dapueto R, et al. Among authors: fernandez m. Bioorg Med Chem Lett. 2011 Dec 1;21(23):7102-6. doi: 10.1016/j.bmcl.2011.09.106. Epub 2011 Oct 1. Bioorg Med Chem Lett. 2011. PMID: 22014828

6

Synthesis of 99mTc-nimotuzumab with tricarbonyl ion: in vitro and in vivo studies.

Garcia MF, Camacho X, Calzada V, Fernandez M, Porcal W, Alonso O, Gambini JP, Cabral P. Garcia MF, et al. Among authors: fernandez m. Curr Radiopharm. 2012 Jan;5(1):59-64. doi: 10.2174/1874471011205010059. Curr Radiopharm. 2012. PMID: 22074480

7

Preparation and primary bioevaluation of 99mTc-labeled-1-thio-β-D-glucose as melanoma targeting agent.

Castelli R, Fernández M, Porcal W, Gambini JP, Alonso O, Chabalgoity A, Moreno M, Cabral P. Castelli R, et al. Among authors: fernandez m. Curr Radiopharm. 2011 Oct;4(4):355-60. doi: 10.2174/1874471011104040355. Curr Radiopharm. 2011. PMID: 22202158

8

A potencial theranostic agent for EGF-R expression tumors: (177)Lu-DOTA-nimotuzumab.

Calzada V, Zhang X, Fernandez M, Diaz-Miqueli A, Iznaga-Escobar N, Deutscher SL, Balter H, Quinn TP, Cabral P. Calzada V, et al. Among authors: fernandez m. Curr Radiopharm. 2012 Oct;5(4):318-24. doi: 10.2174/1874471011205040318. Curr Radiopharm. 2012. PMID: 22280117

9

Synthesis and evaluation of (99m)Tc chelate-conjugated bevacizumab.

Camacho X, García MF, Calzada V, Fernández M, Porcal W, Alonso O, Gambini JP, Cabral P. Camacho X, et al. Among authors: fernandez m. Curr Radiopharm. 2013 Mar;6(1):12-9. doi: 10.2174/1874471011306010003. Curr Radiopharm. 2013. PMID: 23035645

10

[(99m)Tc(CO)(3)]-radiolabeled bevacizumab: in vitro and in vivo evaluation in a melanoma model.

Camacho X, García MF, Calzada V, Fernández M, Chabalgoity JA, Moreno M, Barbosa de Aguiar R, Alonso O, Gambini JP, Chammas R, Cabral P. Camacho X, et al. Among authors: fernandez m. Oncology. 2013;84(4):200-9. doi: 10.1159/000338961. Epub 2013 Jan 15. Oncology. 2013. PMID: 23328435

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,557 results

Search Page